Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **14-3-3 protein–B-Raf complex** is a dynamic protein–protein interaction critical for RAF kinase regulation in signal transduction pathways, including the MAPK/ERK pathway[1][2]. 14-3-3 proteins are dimeric adaptors that bind phosphorylated motifs on B-Raf, influencing its activation state: they can inhibit B-Raf by stabilizing an autoinhibited conformation when bound to specific phosphorylated serines, or promote activation and dimerization under other phosphorylation states[1][6]. This complex acts as a central node in growth factor and oncogenic signaling. Targeting this protein–protein interface is under investigation for cancer therapy, particularly given its role in MAPK pathway-driven tumors, but presents challenges due to the ubiquitous cellular roles of 14-3-3 proteins[1][6][2][5][7].
Inhibition of RAF kinase activity by preventing or destabilizing 14-3-3/B-Raf interaction Stabilization of autoinhibited B-Raf conformation by promoting 14-3-3 binding at inhibitory phospho-sites Inhibition of oncogenic B-Raf signaling by blockade of dimerization or membrane translocation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 14-3-3 protein–B-Raf complex.